Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
18 Mar 2019 NICE Issues Technology Appraisal Guidance on Tisagenlecleucel for Treating Relapsed or Refractory DLBCL Haematologic malignancies - Cancer Immunology and Immunotherapy
14 Mar 2019 Cancer Neoantigens: Implications for Immune Response and Cancer Immunotherapy Translational research - Cancer Immunology and Immunotherapy
13 Mar 2019 Persistent Long-term Fatigue Among Epithelial Ovarian Cancer Survivors Gynaecologic malignancies
11 Mar 2019 FDA Approves Atezolizumab for PD-L1 Positive Unresectable Locally Advanced or Metastatic TNBC Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
08 Mar 2019 NICE Issues Technology Appraisal Guidance on Encorafenib with Binimetinib Melanoma and other skin tumours - Personalised medicine - Anticancer agents & Biologic therapy
07 Mar 2019 NICE Issues Technology Appraisal Guidance on Abemaciclib with an Aromatase Inhibitor Breast cancer - Anticancer agents & Biologic therapy
06 Mar 2019 Biosimilars have a fascinating story of development and understanding it is crucial for widespread adoption
06 Mar 2019 EMA Recommends Approval of Pazenir for the Treatment of Metastatic Breast Cancer and NSCLC Breast cancer - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
05 Mar 2019 EMA Recommends Granting a Conditional Marketing Authorisation for Lorlatinib Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
04 Mar 2019 EMA Recommends an Extension of Indications for Olaparib Breast cancer - Personalised medicine - Anticancer agents & Biologic therapy
01 Mar 2019 FDA Approves New Formulation of Herceptin for Subcutaneous Use Breast cancer - Anticancer agents & Biologic therapy
27 Feb 2019 FDA Approves Trifluridine/Tipiracil for Recurrent, Metastatic Gastric and Gastro-oesophageal Junction Adenocarcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
20 Feb 2019 FDA Approves Pembrolizumab for Adjuvant Treatment of Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
19 Feb 2019 Neoadjuvant PD-1 Blockade in Glioblastoma Central nervous system malignancies - Cancer Immunology and Immunotherapy
18 Feb 2019 Role of Big Data for Evaluation and Supervision of Medicines in the EU Bioethics, legal and economic issues - Personalised medicine